Literature DB >> 14514575

Elevated C-reactive protein is a risk factor for the development of type 2 diabetes in Japanese Americans.

Shuhei Nakanishi1, Kiminori Yamane, Nozomu Kamei, Masamichi Okubo, Nobuoki Kohno.   

Abstract

OBJECTIVE: Increasing evidence from a cohort of Caucasians recently suggests that an elevated level of C-reactive protein (CRP) is associated with an increased risk of developing type 2 diabetes. However, Japanese subjects are skewed to lower CRP concentrations than westerners. Therefore, the effect of CRP on the development of type 2 diabetes among Japanese is unclear. RESEARCH DESIGN AND METHODS: We examined 396 male and 551 female nondiabetic Japanese Americans who underwent a 75-g oral glucose tolerance test (GTT) and were then followed for an average of 6.5 years. We investigated whether elevated serum CRP level is a risk factor in the development of type 2 diabetes among these subjects.
RESULTS: Subjects with a high CRP level showed a significantly higher incidence of type 2 diabetes compared with subjects with a low level among both men (P = 0.028) and women (P = 0.004) in a log-rank test. In a Cox proportional hazards model dividing quartiles of CRP, the hazard ratios for diabetes development in the highest versus lowest quartile of CRP levels were 2.84 (95% CI 1.09-7.39) among men and 3.11 (1.25-7.75) among women after adjustment for age, smoking, family history of diabetes, classification of a 75-g GTT, hormone replacement therapy (among women), BMI, and homeostasis model assessment.
CONCLUSIONS: Among Japanese Americans, CRP may be a risk factor for development of type 2 diabetes independent of either obesity or insulin resistance. Our results suggest that inflammation may be closely related to the mechanism of type 2 diabetes among Japanese Americans.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14514575     DOI: 10.2337/diacare.26.10.2754

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  41 in total

1.  Common variations in the genes encoding C-reactive protein, tumor necrosis factor-alpha, and interleukin-6, and the risk of clinical diabetes in the Women's Health Initiative Observational Study.

Authors:  Kei-hang K Chan; Kathleen Brennan; Nai-chieh Y You; Xuyang Lu; Yiqing Song; Yi-Hsiang Hsu; Gautum Chaudhuri; Lauren Nathan; Lesley Tinker; Simin Liu
Journal:  Clin Chem       Date:  2010-12-13       Impact factor: 8.327

2.  Reply to letter inflammatory markers in patients with obstructive sleep apnea.

Authors:  Woo Hyun Lee; Jeong-Whun Kim
Journal:  Sleep Breath       Date:  2016-01-11       Impact factor: 2.816

3.  Inflammatory markers in patients with obstructive sleep apnea.

Authors:  Tomoyuki Kawada
Journal:  Sleep Breath       Date:  2016-01-11       Impact factor: 2.816

4.  Estimation of the contribution of biomarkers of different metabolic pathways to risk of type 2 diabetes.

Authors:  Jukka Montonen; Dagmar Drogan; Hans-Georg Joost; Heiner Boeing; Andreas Fritsche; Erwin Schleicher; Matthias B Schulze; Tobias Pischon
Journal:  Eur J Epidemiol       Date:  2010-12-28       Impact factor: 8.082

Review 5.  The use of high-sensitivity assays for C-reactive protein in clinical practice.

Authors:  Kiran Musunuru; Brian G Kral; Roger S Blumenthal; Valentin Fuster; Catherine Y Campbell; Ty J Gluckman; Richard A Lange; Eric J Topol; James T Willerson; Milind Y Desai; Michael H Davidson; Samia Mora
Journal:  Nat Clin Pract Cardiovasc Med       Date:  2008-08-19

6.  Association between C-reactive protein and type 2 diabetes in a Tunisian population.

Authors:  Hanen Belfki; Samir Ben Ali; Souha Bougatef; Decy Ben Ahmed; Najet Haddad; Awatef Jmal; Monia Abdennebi; Habiba Ben Romdhane
Journal:  Inflammation       Date:  2012-04       Impact factor: 4.092

7.  Serological evidence of infections and Type 2 diabetes: the MultiEthnic Study of Atherosclerosis.

Authors:  P L Lutsey; J S Pankow; A G Bertoni; M Szklo; A R Folsom
Journal:  Diabet Med       Date:  2009-02       Impact factor: 4.359

Review 8.  The role of insulin-like growth factor-I and its binding proteins in glucose homeostasis and type 2 diabetes.

Authors:  Swapnil N Rajpathak; Marc J Gunter; Judith Wylie-Rosett; Gloria Y F Ho; Robert C Kaplan; Radhika Muzumdar; Thomas E Rohan; Howard D Strickler
Journal:  Diabetes Metab Res Rev       Date:  2009-01       Impact factor: 4.876

9.  Predictive factors of non-deterioration of glucose tolerance following a 2-year behavioral intervention.

Authors:  Bianca Almeida-Pititto; Amélia T Hirai; Daniela S Sartorelli; Helena A Harima; Suely Ga Gimeno; Sandra Rg Ferreira
Journal:  Diabetol Metab Syndr       Date:  2010-07-30       Impact factor: 3.320

10.  C-reactive protein genotype affects exercise training-induced changes in insulin sensitivity.

Authors:  Thomas O Obisesan; Christiaan Leeuwenburgh; Robert E Ferrell; Dana A Phares; Jennifer A McKenzie; Steven J Prior; James M Hagberg
Journal:  Metabolism       Date:  2006-04       Impact factor: 8.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.